Business · 15/12/1994Updated: 10/18/2026 · 1 min read
FDA Corrects Notice on Withdrawal of Fujisawa USA, Inc.'s New Drug Application Approval
Summary
The Food and Drug Administration (FDA) is correcting a notice that withdrew approval of a new drug application (NDA) held by Fujisawa USA, Inc. due to an inadvertent error in the document published on November 3, 1994 (59 FR 55120).
Original source language: Federal Register — Health and Human ServicesOpen original release →